They made it sound like this peptide is the superhero of recovery, swooping in to save the day
Not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease.
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Daily B12 injections are especially crucial if you show neurological symptoms of B12 deficiency
Participants with normal renal function had a slightly lower total cagrilintide exposure (AUC 0 ) compared with participants with renal impairment, but without a trend across the different renal impairment groups
Having enough B12 is important for the babys growth and health